Development and molecular characterization of hard-to-treat breast cancer pre-clinical models to enhance precision medicine

被引：0
|
作者：
Kuasne, Hellen
Fortier, Anne-Marie
Busque, Sandrine
Mathien, Simon
Savage, Paul
Ramirez, Constanza Martinez
Monast, Anie
Soleinova, Margarita
Omeroglu, Atilla
Asselah, Jamil
Bouganim, Nathaniel
Meterissian, Sarkis
Basik, Mark
Park, Morag
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P3-08-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-08-09
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Development of advanced pre-clinical in vivo models of metastatic breast cancer
    Okano, Maiko
    Kawaguchi, Tsutomu
    Okano, Ichiro
    Katsuta, Eriko
    Takabe, Kazuaki
    CANCER RESEARCH, 2018, 78 (04)
  • [2] Development and Comparative Characterization of Metastasis in Newly Developed Pre-Clinical Models of Inflammatory Breast Cancer.
    Chu, K.
    Mu, Z.
    Alpaugh, K. R.
    Fernandez, S.
    Freiter, E. M.
    Wu, H.
    Zook, M. B.
    Barsky, S. H.
    Cristofanilli, M.
    Robertson, F. M.
    CANCER RESEARCH, 2011, 71
  • [3] Terry Fox PRecision Oncology For Young peopLE (PROFYLE): A Canadian precision medicine program for children, adolescents and young adults with hard-to-treat cancer
    Grover, Stephanie A.
    Berman, Jason N.
    Chan, Jennifer A.
    Deyell, Rebecca J.
    Eisenstat, David D.
    Fernandez, Conrad, V
    Grundy, Paul E.
    Hawkins, Cynthia
    Irwin, Meredith S.
    Jabado, Nada
    Jones, Steven J.
    Moran, Michael
    Rassekh, Shahrad R.
    Shlien, Adam
    Sinnett, Daniel
    Sorensen, Poul H.
    Sullivan, Patrick J.
    Taylor, Michael D.
    Villani, Anita
    Whitlock, James A.
    Malkin, David
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Breast cancer immune microenvironment: from pre-clinical models to clinical therapies
    Wilson, Brooke E.
    Gorrini, Chiara
    Cescon, David W.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (02) : 257 - 267
  • [5] Breast cancer immune microenvironment: from pre-clinical models to clinical therapies
    Brooke E. Wilson
    Chiara Gorrini
    David W. Cescon
    Breast Cancer Research and Treatment, 2022, 191 : 257 - 267
  • [6] Pleiotriphin and midkine promote metastasis in pre-clinical models of breast cancer
    Sorrelle, N.
    Dominguez, A.
    Dominguez, Ganguly D.
    Huang, H.
    Eric, Berens
    Jason, Toombs
    Poczobutt, J.
    Rosenfield, S.
    Du, W.
    Nemenoff, R.
    Wellstein, A.
    Brekken, R.
    CLINICAL & EXPERIMENTAL METASTASIS, 2019, 36 (02) : 169 - 169
  • [7] Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials
    Yarla, Nagendra S.
    Madka, Venkateshwar
    Pathuri, Gopal
    Rao, Chinthalapally V.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 20
  • [8] Preclinical Molecular Imaging for Precision Medicine in Breast Cancer Mouse Models
    Fiordelisi, M. F.
    Auletta, L.
    Meomartino, L.
    Basso, L.
    Fatone, G.
    Salvatore, M.
    Mancini, M.
    Greco, A.
    CONTRAST MEDIA & MOLECULAR IMAGING, 2019, 2019
  • [9] Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
    Toru Hanamura
    Jessica L. Christenson
    Kathleen I. O’Neill
    Emmanuel Rosas
    Nicole S. Spoelstra
    Michelle M. Williams
    Jennifer K. Richer
    Breast Cancer Research, 23
  • [10] Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
    Hanamura, Toru
    Christenson, Jessica L.
    O'Neill, Kathleen, I
    Rosas, Emmanuel
    Spoelstra, Nicole S.
    Williams, Michelle M.
    Richer, Jennifer K.
    BREAST CANCER RESEARCH, 2021, 23 (01)
12345